| Bob Wynn, MD | |
|
10163 Se Sunnyside Rd Ste 490, Clackamas, OR 97015-5720 | |
| (855) 632-8280 | |
| (503) 513-4424 |
| Full Name | Bob Wynn |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 10163 Se Sunnyside Rd Ste 490, Clackamas, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992061436 | NPI | - | NPPES |
| Entity Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed for Orphan Drug Designation with the U.S. Food and Drug Administration (FDA) for INFRADURE for the treatment of hepatitis D.
In its submission to the Senate Standing Committee on Community Affairs regarding the Commonwealth funding and administration of mental health services, the Royal Australian College of General Practitioners (RACGP) strongly argued for the restoration of GP mental health services. The College is gravely concerned regarding the proposed cuts to the Better Access program and the subsequent impact on mental health delivery for every patient age group, demographic and geography throughout Australia.
Drugs continue to be the fastest-growing category of health care spending in Canada and a new report released by the Canadian Institute for Health Information (CIHI), the Drug Expenditure in Canada 1985-2004 report, shows that total spending on drugs is expected to have reached $21.8 billion in 2004, five times the amount spent on drugs in 1985.
Nexidia, a leading provider of customer interaction analytics solutions for business transformation, today announced that Blue Cross and Blue Shield of North Carolina (BCBSNC) has selected Nexidia's Enterprise Speech Intelligence (ESI) solution to support the company in determining enhancements to its service center operations.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bob Wynn, MD 10180 Se Sunnyside Rd, Clackamas, OR 97015-8970 Ph: (503) 249-3434 | Bob Wynn, MD 10163 Se Sunnyside Rd Ste 490, Clackamas, OR 97015-5720 Ph: (855) 632-8280 |
News Archive
Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed for Orphan Drug Designation with the U.S. Food and Drug Administration (FDA) for INFRADURE for the treatment of hepatitis D.
In its submission to the Senate Standing Committee on Community Affairs regarding the Commonwealth funding and administration of mental health services, the Royal Australian College of General Practitioners (RACGP) strongly argued for the restoration of GP mental health services. The College is gravely concerned regarding the proposed cuts to the Better Access program and the subsequent impact on mental health delivery for every patient age group, demographic and geography throughout Australia.
Drugs continue to be the fastest-growing category of health care spending in Canada and a new report released by the Canadian Institute for Health Information (CIHI), the Drug Expenditure in Canada 1985-2004 report, shows that total spending on drugs is expected to have reached $21.8 billion in 2004, five times the amount spent on drugs in 1985.
Nexidia, a leading provider of customer interaction analytics solutions for business transformation, today announced that Blue Cross and Blue Shield of North Carolina (BCBSNC) has selected Nexidia's Enterprise Speech Intelligence (ESI) solution to support the company in determining enhancements to its service center operations.
› Verified 1 days ago
Dr. Cara Lee Rozell, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 10180 Se Sunnyside Rd, Dept Of Neurology, Clinic C, Clackamas, OR 97015 Phone: 503-571-7200 | |
Cheryl Ann Chessick, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10163 Se Sunnyside Rd, Ste. 490, Clackamas, OR 97015 Phone: 503-249-3434 | |
Dr. Heather Lynn Knott, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12901 Se 97th Ave Ste 105, Clackamas, OR 97015 Phone: 503-912-4788 Fax: 503-912-4787 | |
Dr. Han-chun Liang, M.D., M.B.A. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 10163 Se Sunnyside Rd Ste 490, Clackamas, OR 97015 Phone: 503-249-3434 | |
Dr. Rory E. Green, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 10163 Se Sunnyside Rd, Suite 490, Clackamas, OR 97015 Phone: 503-513-4400 | |
Dr. Christina E Peterson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 15259 Se 82nd Dr, 201b, Clackamas, OR 97015 Phone: 503-656-9844 Fax: 503-656-3120 | |
My Chuong, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 9800 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 800-813-2000 |